Inzy earnings

Web13 apr. 2024 · INZY Inozyme Pharma, Inc. Earnings Date & History 788 followers ( +14.89% 3:59 PM 04/06/23 NASDAQ $USD Pre-Market: $5.68 +0.01 (+0.18%) 6:37 … WebFind the latest Earnings Report Date for Inozyme Pharma, Inc. Common Stock (INZY) at Nasdaq.com. Inozyme Pharma, Inc. Common Stock (INZY) Earnings Report Date …

Inozyme Pharma (INZY) Earnings Date & Reports - TipRanks

Web22 mrt. 2024 · INZY has generated -$2.26 earnings per share over the last four quarters. What is Inozyme Pharma's EPS forecast for next year? Inozyme Pharma's earnings are … Web14 apr. 2024 · RenovoRx (NASDAQ:RNXT – Get Rating) and Inozyme Pharma (NASDAQ:INZY – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, analyst recommendations, institutional ownership and … iproute2alam recipe veenas curryworld https://puntoholding.com

INZY Earnings Date 2024 Inozyme Pharma Earnings Forecast

Web12 apr. 2024 · Check if INZY Stock has a Buy or Sell Evaluation. INZY Stock Price (NASDAQ), Forecast, Predictions, ... The upcoming earnings date for Inozyme Pharma, Inc. is 2024-05-09 00:00:00. Click to get the best stock tips daily for … WebOn Invalid Date, Inozyme Pharma (NASDAQ: INZY) reported Q4 2024 earnings per share (EPS) of -$0.42, up 46.84% year over year. Total Inozyme Pharma earnings for the quarter were -$18.54 million. In the same quarter last year, Inozyme Pharma's earnings per share (EPS) was -$0.79. Web13 apr. 2024 · We are developing INZ-701, an enzyme therapy, to address pathologic mineralization and intimal proliferation which can drive morbidity and mortality in these severe diseases. INZ-701 is currently in Phase 1/2 clinical trials for the treatment of ENPP1 Deficiency and ABCC6 Deficiency. View Corporate Presentation Stock Quote Change iprov230win_web.exe

Inozyme Pharma, Inc. (INZY) - Yahoo Finance

Category:Inozyme Pharma, Inc. (INZY) - Yahoo!

Tags:Inzy earnings

Inzy earnings

INZY - Inozyme Pharma, Inc. Stock Price and Quote - FINVIZ.com

WebInozyme Pharma (INZY) Earnings, Revenues Date & History. Earnings. Revenues. The upcoming earnings date is based on a company’s previous reporting, and may be … WebINZY Complete Inozyme Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Inzy earnings

Did you know?

WebInozyme Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. INZY updated stock price target summary. Dow Jones, a News Corp company About WSJ WebQuarterly Numbers. Actuals. Estimates. INZY will report Q1 2024 earnings on 09/07/2024. Q1 2024. Q2 2024. Q3 2024.

Web27 mrt. 2024 · Shares of NASDAQ:INZY opened at $3.60 on Monday. The company has a debt-to-equity ratio of 0.03, a current ratio of 8.93 and a quick ratio of 11.11. Inozyme Pharma has a 1-year low of $0.99 and a ... Web29 mrt. 2024 · Inozyme Pharma, Inc. (NASDAQ:INZY – Get Rating) – Jefferies Financial Group issued their Q1 2024 earnings estimates for shares of Inozyme Pharma in a research note issued on Wednesday, March 22nd.Jefferies Financial Group analyst S. Jeong anticipates that the company will earn ($0.44) per share for the quarter. Jefferies …

Web16 mrt. 2024 · This suggests that analysts have very recently bumped up their estimates for INZY, giving the stock a Zacks Earnings ESP of +12.11% heading into earnings season. Inozyme Pharma, Inc. Price... Web27 mrt. 2024 · Inozyme Pharma, Inc. (NASDAQ:INZY – Get Rating) – Equities researchers at Wedbush upped their Q1 2024 earnings estimates for shares of Inozyme Pharma in a report issued on Wednesday, March 22nd.

Web22 mrt. 2024 · The following information was filed by Inozyme Pharma, Inc. (INZY) on Wednesday, March 22, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the …

orc stopped in roadwayWeb25 mrt. 2024 · INZY opened at $3.60 on Friday. Inozyme Pharma has a one year low of $0.99 and a one year high of $6.25. The company has a market cap of $145.42 million, a P/E ratio of -1.90 and a beta of 0.79. orc stomp eqWeb12 apr. 2024 · Inozyme Pharma Inc., whose market valuation is $224.17 million at the time of this writing, is expected to release its quarterly earnings report May 08, 2024 – May 12, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable. orc stop at sidewalkWeb11 apr. 2024 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Inozyme Pharma stock is Buy based on the current 4 buy ratings for INZY. The … orc stop lightWeb13 apr. 2024 · We use cookies to personalize content and ads, provide social media features, and, analyze our traffic. We also share information about your use of our site … orc stop light violationWebInozyme (INZY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. GlobeNewswire. Inozyme Pharma to Participate in the Cowen 43rd Annual Health Care Conference. BOSTON, March 01, 2024 (GLOBE NEWSWIRE) ... orc stony brookWeb11 apr. 2024 · NASDAQ:INZY Inozyme Pharma - INZY Price Target & Analyst Ratings $5.67 +0.74 (+15.01%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $4.88 $6.20 50-Day Range $2.20 $5.73 52-Week Range $0.99 $6.20 Volume 2.41 million shs Average Volume 1.05 million shs Market Capitalization $247.89 million P/E Ratio N/A … iproven basal thermometer